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ABSTRACT
Objective: To investigate the risk of cancer and potential
gender effects in persons hospitalised with burn injury.
Design: Population-based retrospective cohort study using
record-linkage systems in Scotland and Western Australia.
Participants: Records of 37 890 and 23 450 persons
admitted with a burn injury in Scotland and Western
Australia, respectively, from 1983 to 2008. Deidentified
extraction of all linked hospital morbidity records, mortality
and cancer records were provided by the Information
Service Division Scotland and the Western Australian Data
Linkage Service.
Main outcome measures: Total and gender-specific
number of observed and expected cases of total (‘all sites’)
and site-specific cancers and standardised incidence ratios
(SIRs).
Results: From 1983 to 2008, for female burn survivors,
there was a greater number of observed versus expected
notifications of total cancer with 1011 (SIR, 95% CI 1.3, 1.2
to 1.4) and 244 (SIR, 95% CI 1.12, 1.05 to 1.30),
respectively, for Scotland and Western Australia. No
statistically significant difference in total cancer risk was
found for males. Significant excesses in observed cancers
among burn survivors (combined gender) in Scotland and
Western Australian were found for buccal cavity, liver, larynx
and respiratory tract and for cancers of the female genital
tract.
Conclusions: Results from the Scotland data confirmed
the increased risk of total (‘all sites’) cancer previously
observed among female burn survivors in Western
Australia. The gender dimorphism observed in this study
may be related to the role of gender in the immune
response to burn injury. More research is required to
understand the underlying mechanism(s) that may link burn
injury with an increased risk of some cancers.
INTRODUCTION
The burden of burn injury is a significant
issue, not only in terms of the acute care per-
spective but also the chronic health effects
resulting from the injury event and the subse-
quent treatments. While burns predominantly
affect the skin, burns are associated with sig-
nificant systemic effects,1–3 depressed immune
functioning4–8 and prolonged periods of sys-
temic catabolism and hypermetabolism.9
Prompted by a clinical scenario of a diagnosis
of hepatocellular carcinoma in a young male
burn patient,10 and the potential for malig-
nancy after burn, an initial study of burn
injury and total (all sites) cancer risk was
undertaken.11
Results of our initial study demonstrated a
gender effect with female burn survivors
having an increased risk of all types of
cancer.11 In contrast to our results, a Swedish
population-based study12 that linked burn
patient hospitalisation records and cancer
registrations reported the risk of developing
any form of cancer for combined gender was
increased (standardised incidence ratio
(SIR), 95% CI 1.11, 1.06 to 1.16), with the
risk of lung cancer also significantly
increased (SIR, 95% CI 1.39, 1.21 to 1.59).
However, a Danish study of burn patients13
found no significant increases in cancer
(combined gender) for all malignant neo-
plasms, including all skin cancers (SIR, 95%
CI 0.99, 0.93 to 1.06).
This previous study of burn injury and
cancer risk used population-based data
linked by the Western Australian Data
Strengths and limitations of this study
▪ Population-level linked administrative data min-
imise the issues of selection and reporting bias,
and loss to follow-up.
▪ Consistency of results using population-level
data from two patient populations provides a
greater support for link between burn injury and
some cancers.
▪ Unable to examine the impact of burn severity
on cancer risk due to lack of available data.
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Linkage System (WADLS).14 Western Australia has a
population of approximately 2.2 million, and as such,
did not support detailed gender-specific and site-specific
cancer incidence assessments with adequate statistical
power. While the WADLS has linked datasets of Western
Australians since the 1970s, other Australian states have
only recently established record linkage systems and
were not able to support this study. To extend the popu-
lation base and enable further detailed examination of
the observed gender effect and site-specific cancer inci-
dence, approval was sought to access the Scottish
population-based record linkage system, the Information
Service Division (ISD) Scotland,15 that has routinely
linked health data since the 1980s.
This article reports a retrospective longitudinal study
to explore cancer risk after burn injury using linked hos-
pital morbidity, cancer and death data of persons hospi-
talised for burn injury in Western Australia and
Scotland. The study aimed to, first, confirm the
increased risk of total (‘all sites’) cancer observed in the
preliminary Western Australian study of female burn sur-
vivors using the Scottish data; and, second, examine site-
specific cancer risk among survivors of burn injury.
METHODS
Study data were obtained from the WADLS14 and the
ISD (Scotland) of the National Health Service (NHS)
National Services Scotland15. The WADLS and ISD
Scotland are validated record linkage systems that rou-
tinely link administrative health data from core datasets
for the entire population of Western Australia and
Scotland, respectively.
An index burn injury was defined as the first hospital
admission with a burn injury using primary and add-
itional diagnosis International Classification of Diseases
(ICD) codes 940–949 (ICD9) and T20-T31 (ICD10). A
deidentified extraction of all linked hospital morbidity
records (Hospital Morbidity Data System (HMDS), mor-
tality (Death Register, Western Australia) and cancer
records (Western Australia Cancer Registry (WACR)) for
all persons admitted to hospital with an index burn
injury in Western Australia, for the period 1 January
1983 to 31 December 2008, was performed by WADLS.16
A corresponding deidentified extraction of all linked
hospital morbidity records (Scottish Morbidity Records
(SMR) 01), cancer registrations (SMR06) and death
records (General Register Office for Scotland (GROS))
using the same burn cohort definition was undertaken
by ISD Scotland. Hospital admissions data items
included age at admission, gender, admission date, sep-
aration (or discharge) date, principal and additional
diagnoses and external cause of injury.
The WACR was established in 1981 and is a
population-based cancer registry based on mandatory
notification of cancers from pathologists, haematologists
and radiation oncologist, and cancer information from
death records.17 Malignant cancers are coded according
to a modified Australian version of the International
Classification of Diseases, Tenth Revision (ICD10-AM)
and International Classification of Diseases for Oncology
(ICD-O-3).
The Scotland Cancer Registry (SMR06) has recorded
all incident cancers in Scotland from 1958, and since
1997 registration has been centralised at ISD Scotland.18
The registry is responsible for the collection of informa-
tion on all new cases of primary malignant neoplasms,
carcinoma in situ (including grade III intraepithelial
neoplasia), neoplasms of uncertain behaviour and
(since 1 January 2000) benign brain and spinal cord
tumours arising in residents of Scotland. Data quality is
monitored using routine indicators, computer validation
and ad hoc studies of data accuracy and completeness of
ascertainment.19 20 The Scottish cancer notifications are
coded using the ICD V.10 and the ICD-O.
Methods for analysis have been previously published.11
An incident cancer was defined as a cancer diagnosis
notification (C00-C96, excluding C44) after hospital
admission for index burn injury. Analysis was restricted
to malignant neoplasm notifications (C00-C96, exclud-
ing C44) for which total (all sites) and site-specific
cancer incident rates were provided by WACR and ISD
Scotland for respective populations. Records were
excluded from the analysis if the date of cancer diagno-
sis was prior to date of discharge for index burn hospi-
talisation. When a record was identified as having more
than one malignant neoplasm notification, each neo-
plasm was counted as an individual record; however, if
multiple tumours of the skin (C43) with identical mor-
phological characteristics (ie, the first three digits
ICD-O-3 morphology code) were identified, they were
recorded only once. Gender and age-specific cancer
(total C00-C96, excluding C44) incident rates for the
Western Australian and Scottish populations were
pooled for the calendar periods 1983–1988, 1989–1993,
1994–1998, 1999–2003 and 2004–2008 to allow for
changes in population cancer incidence during the
study period.
For the determination of incident rates, the calcula-
tion of person-years began on the day of final hospital
discharge for the index burn admission, and the study
observation period continued until date of the defined
cancer diagnosis, death or 31 December 2008, which-
ever occurred first. Individual calculations were con-
ducted for total (all sites) and site-specific cancers. The
observed number of cases of cancer and person-years at
risk were calculated by age (5-year age groups), gender
and calendar period (1983–1988, 1989–1993, 1994–
1998, 1999–2003 and 2004–2008). The expected
number of cancer cases was estimated by multiplying the
specific number of person-years per category by the cor-
responding incidence of cancer in Western Australia,
Scotland, and combined cancer incidence rates, pro-
vided by WACR and ISD Scotland. SIRs were calculated
by dividing the observed number of cases by the
number expected.21 22 The 95% CIs were defined under
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the assumption that the observed number of cancers fol-
lowed the Poisson distribution.23
Separate SIR analyses for total (all sites) and site-
specific cancers were conducted using country-specific
data for respective burn patient cohorts (all burn depth)
hospitalised from 1983 to 2008; total (all sites) SIRs were
repeated for subcohorts of burn admissions from 1983
to 1987, with an optimum follow-up time. To further
explore the gender impact of burn injury on cancer
risk, total (all sites) cancer SIR analyses were repeated
on age-restricted subcohorts classified to reflect the
reproductive age at admission for burn injury: <15; 15–
49 and ≥50 years. All statistical analyses were performed
using Stata statistical software V.11 (StataCorp LP,
College Station, Texas, USA).
RESULTS
As previously reported, in Western Australia from 1983 to
2008, there were 23 450 hospital index admissions for burn-
related injury.16 After exclusion of records with a history of
cancer prior to separation date or death during hospital
admission for burn, a total of 22 705 patient records were
included in the analysis.11 There were 673 patients with a
first cancer notification after the date of separation for
burn injury hospitalisation, and with inclusion of multiple
malignancies, 759 cancer notifications were included in the
SIR analyses as independent observations.
In Scotland from 1983 to 2008, there were a total of
37 890 persons hospitalised for an index burn-related
injury. After exclusion of those with a history of cancer
prior to separation date or death during hospital admis-
sion for burn, a total of 37 506 patients were included in
the analysis. There were 2005 patients with a first cancer
notification after the date of separation for burn injury
hospitalisation, and with inclusion of multiple malignan-
cies, 2260 cancer notifications were included in the SIR
analyses as independent observations. The character-
istics of the Western Australia and Scotland cohorts are
presented in table 1.
The Western Australia cohort (1983–2008; combined
gender) was followed for a total of 283 306 person-years, with
a mean follow-up time of 12.3 years (range >0–25.9 years).
The mean follow-up time for those with a cancer notification
was 9.4 years (range >0–25.4 years) and for those with no
cancer notification was 12.4 years (range >0–25.9 years). The
Scotland cohort (1983–2008; combined gender) was fol-
lowed for a total of 474 489 person-years, with a mean
follow-up time of 12.6 years (range 0–26.0 years). The mean
follow-up time for those with a cancer notification was
9.4 years (range >0–25.8 years) and for those with no cancer
notification was 12.7 years (range >0–26 years).
For the Scottish cohort of burn-injury patients (com-
bined gender), there was a marginal but significant dif-
ference (SIR, 95% CI 1.09, 1.05 to 1.10) in the overall
risk of cancer for persons with a burn injury hospitalisa-
tion for the period 1983–2008, compared with the
general population of Scotland. While a significant
increase of 30% in cancer risk was estimated for
females, there was no difference in cancer risk for
males, when compared with the general population of
Scotland (refer to table 2). For the subcohort of burn
injury patients hospitalised during 1983–1988, the total
observed number of cases of cancer (n=838) was statistic-
ally significantly lower than expected (n=953.4) with SIR
(95% CI) of 0.88 (0.82 to 0.94), with males having a stat-
istically significantly lower number of cases observed
than expected. Refer to table 2 for gender-specific SIRs
for total (all sites) cancer for Scotland and Western
Australian burn patients, hospitalised during 1983–1988
and 1983–2008.11
Female genital cancers were grouped due to the small
number of observed cancers in subgroups in the Western
Australian data and unstable SIR results. Statistically
Table 1 Characteristics of burn injury patients included in
analyses with no record of cancer prior to separation date









22 705 3 537 506
Gender: male 15 481 (68.2) 23 896 (63.7)
Age at index admission (years)
<15 8135 (35.8) 14 579 (38.9)
15–24 4364 (19.2) 4495 (12.0)
25–49 7147 (31.5) 9554 (25.5)
50–64 1736 (7.7) 4080 (10.9)
65+ 1323 (5.8) 4798 (12.8)
Site of burn†
Head and neck 6784 (15.4) 7592 (16.1)
Trunk 7553 (17.2) 8815 (21.0)
Hand, wrist, upper
limb
15 801 (35.9) 6984 (14.8)
Hip, lower limb 11 798 (26.8) 9531 (3.4)
Eye 379 (0.9) 1087 (2.3)
Respiratory tract 212 (0.5) 163 (0.3)
Other internal organs 124 (0.3) 165 (0.3)
Multiple regions 656 (1.5) 3677 (7.8)
Unspecified region 694 (1.6) 858 (1.8)
Burn site depth†
Erythema 8929 (20.9) 4815 (11.5)
Partial thickness 18 449 (41.9) 6302 (15.0)
Full thickness 7095 (16.1) 4924 (11.7)
Unspecified 9528 (21.7) 25 869 (61.7)
Calendar period of admission
1983–1988 5431 (23.9) 11 507 (30.7)
1989–1993 4200 (18.5) 7876 (21.0)
1994–1998 4755 (20.9) 7130 (19.0)
1999–2003 4265 (18.9) 5980 (15.9)
2004–2008 4054 (17.9) 5013 (13.4)
Any comorbidity at index burn
Yes 2798 (12.3) 7679 (20.5)
*No previous record of cancer.
†Patients may have multiple burn sites per anatomical region per
depth.
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significant increases in observed genital (combined)
cancers for female burn patients in Western Australia and
Scotland were found. The increased breast cancer inci-
dence was statistically significant among female burn survi-
vors in Scotland. Statistically significant increases in cancer
incidence for combined gender for Western Australia and
Scottish data were observed for cancers of the buccal
cavity, liver and respiratory tract. Refer to table 3 for
gender-specific and site-specific cancer SIRs. For each of
these cancers, female burn survivors in Western Australia
and Scotland had a higher incidence than males when
compared with respective general population data. For the
majority of site-specific cancers selected, female burn sur-
vivors in Western Australia and Scotland had a higher
number of observed cancers than expected, with SIRs of
similar magnitude. However, SIR results for Scottish data
reached statistical significance, reflecting the larger popu-
lation base and respective higher number of cancer
notifications.
Table 4 presents an SIR analyses of total (all sites)
cancer risk repeated on age-restricted subcohorts, classi-
fied to reflect the reproductive age (<15; 15–49 and
≥50 years) at admission for burn injury. For males in
both WA and Scotland, no statistically significant differ-
ences were found across the three age groups. For
female burn survivors in Scotland, the observed number
of total cancer (all sites) exceeded that expected for
each of the three age groups, with statistically significant
results observed for the age groups 15–49 and for those
aged 50 years and older. In the Western Australia data,
excess cancers were observed for those younger than
15 years and for those 50 years and older, with statistical
significance reached for the older age group; for
females aged 15–49 years at burn injury, no difference in
observed and expected total (all sites) cancer was found.
DISCUSSION
Methodological issues
When population-level administrative data are used, data
linkage minimises issues of selection and reporting bias, as
well as loss to follow-up. Data quality of the Western
Australia and Scottish Cancer Registers17 19 20 and hospital
morbidity datasets24 25 are assessed continually for accuracy
and quality. Data of all index burn hospitalisations in
Western Australia and Scotland from 1983 to 2008 were ana-
lysed with a follow-up time from discharge date, allowing for
exclusion of prevalent cancers to support temporality of
burn exposure and incident cancer. Cancer diagnoses from
cancer registries in Western Australia and Scotland were
independent of the record of burn injury in the respective
hospital morbidity datasets. Minor burns treated in emer-
gency departments were not included in the study. The
burn patient cohorts under study are part of the respective
reference populations, and as such, this may have a small
diluting effect in the SIRs. Using parallel datasets from
Western Australia and Scotland, with 2.2 million and 5.5
million populations, respectively, allowed examination of
the consistency of results and trends across the populations.
The Western Australia hospital morbidity data records
the principal diagnosis and up to 20 additional diagnosis
fields, whereas the Scottish morbidity data include the
principal diagnosis and five additional diagnosis fields.
Consequent to the reduced number of additional diagno-
sis fields in the Scottish data, there was an absence of
recorded supplementary total body surface area burned
(TBSA%) data (ICD9 946; ICD10 T31) and a greater use
of ICD codes for burns to multiple regions of the body
(ICD9 946; ICD10 T29) rather than to individual ana-
tomic burn sites, as reflected in table 1. This limited SIR
analyses restricted to more severe burns of TBSA 20% or
greater and incident rate ratio analysis to examine the
effects of severity of burn injury (burn depth and TBSA
%). Previous SIR analyses of total (all sites) cancer risk in
Western Australia showed similar trends in results for all
burn patients (severe and non-severe).11
Although this study had a follow-up period of up to
26 years from the date of separation for admission for
burn injury, the follow-up period for many patients may
not have provided sufficient observation time to enable
identification of all potential malignancies, given the
long latency period for many cancers. Further burn
injury research is planned with comparison cohorts
(non-burn trauma, no injury), using incidence rate ratio
Table 2 SIRs and 95% CIs and observed and expected number for total (all sites) cancer in persons hospitalised for burn
injury in Western Australia and Scotland, during the periods 1983–2008 and 1983–1988
Western Australia* Scotland















0.97 (0.9 to 1.0)
759: 785.5
0.9 (0.8 to 1.0)
515: 569.5
1.1 (1.0 to 1.3)
244: 216.0
1.09 (1.05 to 1.10)
2260: 2075.9
0.96 (0.90 to 1.0)
1249: 1303.2




1.0 (0.9 to 1.1)
294 : 294.9
0.9 (0.8 to 1.0)
190 : 220.3
1.4 (1.1 to 1.7)
104: 74.6
0.9 (0.8 to 0.9)
838: 953.4
0.8 (0.7 to 0.9)
491: 614.3
1.0 (0.9 to 1.2)
347: 339.1
*Western Australian comparison data Duke et al.11
†SIR (95% CI) adjusted for age.
‡SIR (95% CI) adjusted for age and gender.
O:E, observed:expected; SIR (95% CI), standardised incidence ratio (95% CI).
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Table 3 SIRs and 95% CIs and observed and expected numbers for selected types of cancer in persons hospitalised for burns in Western Australia and Scotland, 1983–2008
Cancer Site ICD-10*
Western Australia Scotland















1.4 (1.03 to 1.9)
45: 32.6
1.4 (1.0 to 1.9)
38 : 28.1
1.5 (0.7 to 3.2)
7: 4.6
2.6 (2.2 to 3.1)
117: 45.0
2.4 (1.9 to 2.9)
83: 35.1




1.4 (0.9 to 2.4)
15 : 10.50




1.6 (1.3 to 2.0)
82: 51.4
1.5 (1.1 to 1.9)
53 : 36.1




0.6 (0.3 to 1.1)
10 : 17.0
0.5 (0.2 to 1.1)
7: 13.4
0.8 (0.3 to 2.6)
3: 3.6








0.7 (0.6 to 0.9)
69: 96.3
0.7 (0.5 to 0.9)
45: 69.1
0.9 (0.6 to 1.3)
24: 27.2








2.6 (1.6 to 4.0)
19: 7.4
2.2 (1.3 to 3.7)
14: 6.3
4.7 (2.0 to 11.4)
5: 1.1








0.7 (0.4 to 1.3)
11: 15.3
0.9 (0.5 to 1.7)
9: 10.4
0.4 (0.1 to 1.6)
2: 5.0
1.1 (0.8 to 1.5)
44 : 39.6
1.5 (1.03 to 2.0)
34: 23.4




5.7 (0.9 to 3.3)
10: 5.7
1.5 (0.7 to 3.0)
8: 5.4
6.0 (1.5 to 24.1)
2: 0.3
1.9 (1.4 to 2.5)
39: 21.1






1.4 (1.1 to 1.6)
101: 74.8
1.3 (1.1 to 1.7)
79 : 59.3
1.4 (0.9 to 2.2)
22 : 15.4
1.5 (1.4 to 1.7)
448 : 298.1
1.3 (1.2 to 1.5)
279 : 210.4




0.7 (0.6 to 0.9)
72: 102.0
0.7 (0.6 to 1.0)
57: 77.9
0.6 (0.4 to 1.0)
15: 24.1
0.8 (0.6 to 1.1)”
38 : 48.5








1.3 (0.2 to 9.2)
1: 0.8
1.0 (0.8 to 1.3)
64 : 61.7
1.7 (1.5 to 1.9)
271 : 161.4




Female genital tract (combined)
C51 to C57
1.4 (1.0 to 2.0)
31 : 26.7
1.7 (1.4 to 2.0)
114: 67.2
Male genital tract (combined)
C60 to C63
0.9 (0.8 to 1.1)
141: 150.7




0.8 (0.6 to 0.9)
102: 135.9
1.1 (0.9 to 1.2)
177: 165.5
Kidney, Bladder, UT C64 to C68 0.5 (0.3 to 0.7)”
17: 37.9
0.4 (0.2 to 0.7)
12: 30.9
0.7 (0.3 to 1.7)
5: 7.0
1.2 (1.0 to 1.4)
135: 110.9
1.2 (1.0 to 1.4)
96: 82.8




1.2 (0.7 to 1.9)
16: 13.9
1.0 (0.5 to 1.8)
10: 10.5
1.7 (0.8 to 3.9)
6: 3.5
1.5 (1.1 to 2.0)
39 : 27.0




Lymphomas to all (0.7 to 1.4)
36: 35.5
0.8 (0.5 to 1.2)
20: 26.0
1.7 (1.03 to 2.7)
16 : 9.6
1.1 (0.9 to 1.4)
75 : 68.0
1.1 (0.8 to 1.4)
48 : 45.0
1.2 (0.8 to 1.7)
27 : 23.0
Myeloma/plasma 1.3 (0.7 to 2.3)
11: 8.6
1.3 (0.7 to 2.6)
8 : 6.1
1.2 (0.4 to 3.7)
3: 2.49




1.2 (0.6 to 2.2)
9: 7.8
Leukaemia’s to all 1.1 (0.8 to 1.7)
26: 22.9
1.1 (0.7 to 1.8)
19: 17.0
1.2 (0.6 to 2.5)
7: 6.0






*ICD-10: International Classification of Diseases V.10.
†SIR (95% CI)adjusted for age and gender.
‡SIR (95% CI) adjusted for age (95% CI).



































analyses to explore the patient (including lifestyle
factors such as smoking and alcohol) and injury factors
associated with the observed cancer risk.
Findings
Analysis of the ISD Scotland data confirmed the results
of our previous study: a statistically significant increase
in total (all sites) cancer risk for female burn survivors
with males experiencing no difference. The site-specific
analyses clearly showed statistically significant increases
in the number of observed cancers for combined
gender in the Western Australia and Scottish data for
the buccal cavity, larynx, liver, respiratory tract and
oesophagus. There was also a general trend for
increased cancer risk for a number of selected types of
cancers for females and statistically significant increases
in female genital cancers. Sub group analyses, defined
crudely by reproductive age, did not elucidate any clear
patterns of influence of oestrogen on cancer incidence,
with female burn survivors in Scotland showing an
increased risk across all age groups. For female burn sur-
vivors in WA, an increased risk for total (all sites) cancer
was found for those younger than 15 (prepubescent)
and 50 years and older (postmenopausal). The lack of
gender difference for the subcohort of burn patients in
Scotland hospitalised during 1983–1988 for total (all
sites) cancer risk is difficult to explain. Possible reasons
may include that females sustained less severe (<20%
TBSA) burns during this period; had less comorbidities
and/or had better lifestyle factors than females hospita-
lised for burns during the remainder of the study
period.
The site-specific analyses showed that while statistically
significant increases in female genital cancers were
found, there was also a general trend among female
burn patients for excesses across a number of site-
specific cancers examined, although these excesses did
not always reach statistical significance, possibly due to
small numbers. Statistically significant increases in the
number of observed cancers for combined gender were
found in the Western Australia and Scottish data for the
buccal cavity, larynx, liver, respiratory tract and oesopha-
gus. These results are similar to those found in a Danish
study13 and may be related to tobacco or alcohol use
among this patient population. However, it would be
expected that inhalation injury may also increase the
cancer risk of the upper and lower respiratory tract, and
in the case of the diagnosis of hepatocellular cancer in a
young male (12 years of age) burn patient in Western
Australia,10 tobacco or alcohol use would be most
unlikely attributable agents. Interestingly, the results of
no increase in skin melanoma risk after burn injury in
this study support findings of other population-based
studies.12 13
An alternative explanation for this increased incidence
in cancer postburn may lie in the significant impact a
burn injury has on the immune system, or the sustained
oxidative and metabolic stress that are integral to the
injury response. While burn injury predominantly affects
the skin, it has been shown to cause a significant depres-
sion of humoral and cell-mediated immunity,7 26 27 sus-
tained elevated levels of oxidative stress28 29 and
prolonged elevation of hypermetabolic and stress
hormone levels.30 31 These effects have been demon-
strated to persist for up to 3 years postinjury and can
lead to long-term systemic impacts on other organs of
the body.1 2 32–36 Severe burn injury has been demon-
strated to induce endoplasmic reticulum (ER) stress, in
Table 4 SIRs and 95% CIs and observed and expected number for total (all sites) cancer incidence, for persons
hospitalised for burns in Western Australia and Scotland, by age group, 1983–1988
Age at first burn years
SIR (95% CI)
(observed: expected)
Combined gender* Male† Female†
<15
WA 1.17 (0.82 to 1.68)
(30 : 25)
1.19 (0.77 to 1.84)
(20 : 16)
1.15 (0.62 to 2.14)
(10 : 8.6)
Scotland 0.94 (0.69 to 1.28)
(41 : 43.69)
0.72 (0.47 to 1.12)
(20 : 27.77)
1.32 (0.86 to 2.02)
(21 : 15.92)
15–49
WA 0.87 (0.77 to 0.99)
(273 : 313)
0.87 (0.75 to 1.00)
(197 : 226)
0.86 (0.69 to 1.1)
(76 : 87)
Scotland 1.21 (1.12 to 1.31)
(617 : 509.16)
1.04 (0.94 to 1.16)
(345 : 331.68)
1.53 (1.36 to 1.73)
(272 : 177.48)
≥50
WA 1.02 (0.93 to 1.12)
(456 : 446)
0.91 (0.82 to 1.02)
(298 : 326)
1.32 (1.13 to 1.54)
(158 : 120)
Scotland 1.05 (1.00 to 1.11)
(1602 : 1523)
0.94 (0.88 to 1.00)
(884 : 943.75)
1.23 (1.15 to 1.33)
(718 : 579.25)
*SIR (95% CI) adjusted for age and gender.
†SIR (95% CI) adjusted for age.
SIR (95% CI), standardised incidence ratio (95% CI); WA, Western Australia.
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particular, in the liver.37 ER stress is a stress-response
that initially facilitates cell survival but can switch to a
proapoptotic signal with prolonged stress.37 38 However,
it has also been shown that the ER stress response can
become maladaptive, facilitating adaptation to hypoxic
environments and promoting tumour growth.38 39 It is
plausible that the array of host responses combined with
the impact of the injury, therefore, creates an environ-
ment of increased susceptibility to cancer.
In addition to the observed increase in some of the
selected site-specific cancers, the data support evidence
for a gender dimorphism (a systematic difference
between individuals of different sex in the same species)
in response to burn injury. After burn injury, gender has
been shown to be an important factor with respect to
poorer outcomes for mortality40–43 and improved prog-
nosis for multiple organ dysfunction syndrome,44 and
sepsis,45 for females compared with males. Similar
gender-based differences have also been reported in
animal studies of burn injury.46–50
The impact of gender with respect to outcomes after
burn injury is largely thought to stem from well-established
differences in immune biology. There is a substantial
volume of published literature to support a gender
dimorphism in the immune response51–54 and sepsis45 fol-
lowing injury that have impacts on health and mortal-
ity.41 42 The majority of these studies support a more
efficient and effective innate and adaptive immune
responses in females, leading to a rapid clearance of infec-
tious organisms driven by tissue resident cell popula-
tions.55 This ‘advantageous’ response reduces the risk of
infection in females compared with males55 56 but leads to
elevated risk of autoimmune disease.57 This dimorphism
was thought to arise largely due to the impact of oestrogen
on immune function.58 59 However, recent papers have
demonstrated that these differences are not completely
ablated by ovariectomy (in animal models)55 and others
have shown that oestrogen can be deleterious to the
immune response.60 This suggests a role of other media-
tors, most likely expressed on the X chromosome, in the
maintenance of the differential immune response.61 62
The evidence for gender differences in the immune
response, to thermal and other trauma, and its impact on
outcomes is substantial. Here, the evidence of an
increased cancer incidence in selected types of cancer
after burn injury, with a greater effect in females, suggests
the systemic immune response to burn injury may be a
mediator of cancer susceptibility.
CONCLUSION
Using population-based linked data of all burn patients in
Western Australia and Scotland, consistent trends were
found in excesses in cancer notifications for a range of
selected site-specific cancers with an elevated and more
widespread increase in female burn patients. Overall,
however, the increased cancer risk affected a small propor-
tion of the respective burn patient cohorts. More research is
required to understand the underlying mechanism(s) that
may link burn injury to an increased risk of some cancers
and why this is elevated in females, which may in turn
enable identification of possible sites for intervention.
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